skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pembrolizumabQuestion & answer

pembrolizumab · Medicine question

Can pembrolizumab cause immune-mediated pneumonitis?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, immune-mediated pneumonitis is listed as an adverse reaction to Keytruda (pembrolizumab).

Sources for this answer

KEYTRUDA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 64Document updated 14 May 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about pembrolizumab

Can pembrolizumab cause type 1 diabetes with ketoacidosis?Has pembrolizumab (Keytruda) been studied in patients with severe renal impairment?Is a validated test required when pembrolizumab treatment eligibility depends on MSI-H or dMMR tumour status?Which severe skin reactions are listed for pembrolizumab?How long should women of childbearing potential continue effective contraception after their last dose of pembrolizumab?How much polysorbate 80 does Keytruda (pembrolizumab) 25 mg/mL concentrate for solution for infusion contain per mL?

pembrolizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the pembrolizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX